Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Programmed Death-1 and Programmed Death-Ligand 1 Expression Patterns in Pediatric Lymphoma

Akihiro Tamura, MD PhD, Makiko Yoshida, MD PhD, Nobuyuki Yamamoto, MD PhD, Nanako Nino, MD, Naoko Nakatani, MD, Takayuki Ichikawa, MD, Sayaka Nakamura, MD, Atsuro Saito, MD, Aiko Kozaki, MD, Kenji Kishimoto, MD, Toshiaki Ishida, MD PhD, Daiichiro Hasegawa, MD PhD, Yoshiyuki Kosaka, MD PhD

Blood (2018) 132 (Supplement 1): 5316.

https://doi.org/10.1182/blood-2018-99-110732

Published: 2018

Journal Articles

Nivolumab As Salvage Therapy in Pediatric Patients with Relapsed and Refractory Lymphomas

Nora Naumann-Bartsch, MD, Daniel Stachel, MD, Martin Chada, MD, Torsten Fritscher, MD, Oliver Rompel, MD, Florian Haller, MD, Arndt Hartmann, MD, Wilhelm Wößmann, MD, Markus Metzler, MD

Blood (2016) 128 (22): 5414.

https://doi.org/10.1182/blood.V128.22.5414.5414

Published: 2016

Journal Articles

ONC201/TIC10 Is Effective As a Monoagent and Synergizes with Chemotherapy to Induce Cell Death in Non-Hodgkin Lymphoma

Mala K. Talekar, MD, Josh Allen, PhD, David T. Dicker, Wafik S. El-Deiry, MD PhD FACP

Blood (2014) 124 (21): 5491.

https://doi.org/10.1182/blood.V124.21.5491.5491

Published: 2014

Journal Articles

Lymphoma Patients Secondary to Congenital and Acquired Immunodeficiency Syndroms in a Turkish Pediatric Oncology Center

Nurdan Tacyildiz, Prof, MD, Gulsah Tanyildiz, MD, Gulsan Yavuz, PROF , MD, Emel Unal, MD PROF, Handan Dincaslan, MD, Derya Ozyoruk, Zulfukar Gordu, MD, Aydan Ikinciogullari, POF, MD, Dogu Figen, PROF, MD, Gurses Sahin, MD

Blood (2014) 124 (21): 5445.

https://doi.org/10.1182/blood.V124.21.5445.5445

Published: 2014

Journal Articles

Regulation Of T-ALL Migration By PKCθ and Carma1

Sreenivasa Rao Oruganti, MSc, PhD, Savannah Krebsbach, Francois Asperti-Boursin, PhD, Sumit Patel, Stuart S. Winter, MD, Judy Cannon, PhD

Blood (2013) 122 (21): 4987.

https://doi.org/10.1182/blood.V122.21.4987.4987

Published: 2013

Journal Articles

Yin Yang 1 (YY1) Regulates The Transcription Of The Gene Krüppel-Like Factor 4 ( KLF4 ) In Pediatric Burkitt Lymphoma: Clinical Implications

Mario I Vega, PhD, Alberto Valencia-Hipolito, MD/PhD, Miriam Hernandez-Atenogenes, ChB, Gabriel G Vega, MDVZ/PhD, Hector Mayani, PhD, Sara Huerta-Yepez, PhD, Benjamin Bonavida, Ph.D, Otoniel Martinez-Maza, PhD

Blood (2013) 122 (21): 3004.

https://doi.org/10.1182/blood.V122.21.3004.3004

Published: 2013

Journal Articles

ONC201(TIC10) Induces TRAIL and Cell Death In Preclinical Models Of Pediatric Lymphoma

Mala Kiran Talekar, MD, Joshua E Allen, PhD, Wafik S. El-Deiry, M.D, Ph.D, F.A.C.P

Blood (2013) 122 (21): 1671.

https://doi.org/10.1182/blood.V122.21.1671.1671

Published: 2013

Journal Articles

Partners In Health Generalist/Specialist Twinning: A Health Delivery Model Used in Treating Childhood Lymphoma in Rural Rwanda,

Sara Stulac, MD, Merab Nyishime, RN, Jean Bosco Bigirimana, RN, Alain N Uwumugambi, MD, Sara Chaffee, MD, Leslie E. Lehmann, MD

Blood (2011) 118 (21): 4222.

https://doi.org/10.1182/blood.V118.21.4222.4222

Published: 2011

Journal Articles

Upregulation of KLF4 Expression in Pediatric B-NHL Lymphomas and Its Association with Low EFS and Poor Survival Following Treatment with Chemotherapy

Mario I Vega, PhD, Miriam Hernandez-Atenogenes, ChB, Alberto Valencia, MD, Gabriel G Vega, MDVZ, Altagracia Maldonado-Valenzuela, ChB, Guillermo Ramon, MD, Haiming Chen, James R. Berenson, MD, Otoniel Martinez-Maza, PhD, Hector Mayani, PhD, Sara Huerta-Yepez, PhD, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 5184.

https://doi.org/10.1182/blood.V118.21.5184.5184

Published: 2011

Journal Articles

Childhood Anaplastic Large Cell Lymphoma with Unusual Localization-A Case Report

Aysegul Unuvar, Tugce Uzunhan, Zeynep Karakas, Gulyuz Ozturk, Sema Anak, Leyla Agaoglu, Omer Devecioglu

Blood (2010) 116 (21): 4903.

https://doi.org/10.1182/blood.V116.21.4903.4903

Published: 2010

Journal Articles

Diagnostic Value and Limitations of FDG-PET for the Staging of Childhood Lymphomas.

Edita Kabickova, MD, Jana Votrubova, MD, PhD, David Sumerauer, MD, PhD, Ester Mejstrikova, MD, PhD, Ondrej Hrusak, MD, PhD, Martin Kyncl, MD, Roman Kodet, MD, Prof., Jan Stary, MD, PhD, Otakar Belohlavek, MD, PhD

Blood (2009) 114 (22): 3658.

https://doi.org/10.1182/blood.V114.22.3658.3658

Published: 2009

Journal Articles

HIF-1a Expression and Implication in the Resistance Regulation and Malignancy in Pediatric Lymphomas Non-Hodgkin’s Tissue Arrays

Rosendo Luria-Pérez, Ph.D., Yolanda Rocio Peña-Alonso, M.D., Daniel Dimitri Hernández-Cueto, B.Sc., Altagracia Maldonado-Valenzuela, B.Sc., Guillermina Juliana Baay-Guzmán, B.Sc., Guadalupe Diaz-Elizondo, B.Sc., Luis Andrés Lara-Martínez, B.Sc., Glenda Juárez-Caballero, M.D., Mario I. Vega, PhD, Benjamin Bonavida, PhD, Sara Huerta-Yepez, Ph.D.

Blood (2008) 112 (11): 5308.

https://doi.org/10.1182/blood.V112.11.5308.5308

Published: 2008

Journal Articles

Identification of Critical Phosporylation Sites within NPM-ALK That Regulate JUNB mRNA Translation.

Claudia Fuchs, Paul Vesely, Ms, Isabella Bambach, Silvia Schauer, Werner Linkesch, MD, David W. Sternberg, MD, PhD, Gerald Hoefler, MD, Philipp B. Staber, MD

Blood (2007) 110 (11): 3571.

https://doi.org/10.1182/blood.V110.11.3571.3571

Published: 2007

Journal Articles

Cause-Specific Mortality and Second Cancer Incidence after Non-Hodgkin Lymphoma: A Report from the Childhood Cancer Survivor Study.

Elizabeth C. Bluhm, MD, MPH, Cecile Ronckers, PhD, Robert J. Hayashi, MD, Joseph P. Neglia, MD, MPH, Ann C. Mertens, PhD, Anna T. Meadows, MD, Pauline A. Mitby, MS, Marilyn Stovall, PhD, Leslie L. Robison, PhD, Peter D. Inskip, ScD

Blood (2007) 110 (11): 3579.

https://doi.org/10.1182/blood.V110.11.3579.3579

Published: 2007

Journal Articles

Inhibition of the NPM-ALK Fusion Tyrosine Kinase in Hematopoietic Neoplasia by the Small Molecule Tyrosine Kinase Antagonist TAE684.

David W. Sternberg, MD, PhD, Arghya Ray, PhD, Benjamin H. Lee, MD, PhD, Jennifer Adelsperger, Nicole Duclos, Elizabeth McDowell, Naznin Haq, Patricia Imbach, Osamu Ohmori, Toshiyuki Honda, Markus Warmuth, Doriano Fabbro, PhD, James D. Griffin, MD, Johannes Roesel, PhD

Blood (2006) 108 (11): 828.

https://doi.org/10.1182/blood.V108.11.828.828

Published: 2006

Journal Articles

Successful therapy of convoluted T-lymphoblastic lymphoma in the adult

AM Levine, SJ Forman, PR Meyer, SC Koehler, H Liebman, A Paganini-Hill, A Pockros, RJ Lukes, DI Feinstein

Blood (1983) 61 (1): 92–98.

https://doi.org/10.1182/blood.V61.1.92.92

Published: 1983

NARROW

Programmed Death-1 and Programmed Death-Ligand 1 Expression Patterns in Pediatric Lymphoma

Nivolumab As Salvage Therapy in Pediatric Patients with Relapsed and Refractory Lymphomas

ONC201/TIC10 Is Effective As a Monoagent and Synergizes with Chemotherapy to Induce Cell Death in Non-Hodgkin Lymphoma

Lymphoma Patients Secondary to Congenital and Acquired Immunodeficiency Syndroms in a Turkish Pediatric Oncology Center

Regulation Of T-ALL Migration By PKCθ and Carma1

Yin Yang 1 (YY1) Regulates The Transcription Of The Gene Krüppel-Like Factor 4 ( KLF4 ) In Pediatric Burkitt Lymphoma: Clinical Implications

ONC201(TIC10) Induces TRAIL and Cell Death In Preclinical Models Of Pediatric Lymphoma

Partners In Health Generalist/Specialist Twinning: A Health Delivery Model Used in Treating Childhood Lymphoma in Rural Rwanda,

Upregulation of KLF4 Expression in Pediatric B-NHL Lymphomas and Its Association with Low EFS and Poor Survival Following Treatment with Chemotherapy

Childhood Anaplastic Large Cell Lymphoma with Unusual Localization-A Case Report

Diagnostic Value and Limitations of FDG-PET for the Staging of Childhood Lymphomas.

HIF-1a Expression and Implication in the Resistance Regulation and Malignancy in Pediatric Lymphomas Non-Hodgkin’s Tissue Arrays

Identification of Critical Phosporylation Sites within NPM-ALK That Regulate JUNB mRNA Translation.

Cause-Specific Mortality and Second Cancer Incidence after Non-Hodgkin Lymphoma: A Report from the Childhood Cancer Survivor Study.

Inhibition of the NPM-ALK Fusion Tyrosine Kinase in Hematopoietic Neoplasia by the Small Molecule Tyrosine Kinase Antagonist TAE684.

Successful therapy of convoluted T-lymphoblastic lymphoma in the adult

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only